Richard Pratley

251PUBLICATIONS
545CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Gene and molecular therapyNeurology and neuromuscular diseasesPharmacogenomicsSport and exercise nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (251)

|Oct 13, 2026
Validation of the Klinrisk CKD Progression Model in the Dapagliflozin and Prevention of Adverse Outcomes in CKD (DAPA-CKD) Population.

|Sep 17, 2026
Initial Changes in eGFR during Treatment with Balcinrenone and Dapagliflozin: An Exploratory Analysis of the MIRO-CKD Trial.

|Sep 10, 2026
Coordinated clinical trial networks in nephrology: strengthening research infrastructure and improving trial delivery.

|Sep 04, 2026
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.

|Aug 30, 2026
Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

|Aug 04, 2026
Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKD.

Pageof 42

Frequent Collaborators

43 joint publications

Peter Rossing

34 joint publications

Brendon L Neuen

27 joint publications

Clare G Arnott

23 joint publications

David Z I Cherney